Stem-Cell Therapy Grant

Under a $12.1 million grant, Tippi MacKenzie at the University of California San Francisco will develop a stem cell therapy to treat alpha-thalassemia major, a fetal blood disorder that is usually fatal. The therapy consists of bone marrow-derived hematopoietic stem cells from the mother transplanted into the baby before birth.